Characterization of MazFSa, an endoribonuclease from Staphylococcus aureus

Zhibiao Fu1, Niles P Donegan, Guido Memmi

  • 1Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH 03755, USA.

Journal of Bacteriology
|October 16, 2007
PubMed

Insights

Staphylococcus aureus MazEF(Sa) is a toxin-antitoxin system that halts bacterial growth by cleaving mRNA. Unlike E. coli, its transcription increases with antibiotic exposure, suggesting unique stress responses.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Bacterial Genetics

Background:

  • The mazEF system is a toxin-antitoxin module found in bacteria, regulating cell growth and survival.
  • Staphylococcus aureus mazEF (mazEF(sa)) is known to be co-transcribed with the sigB operon under stress conditions.

Purpose of the Study:

  • To investigate the function and characteristics of the mazEF system in Staphylococcus aureus.
  • To compare the mazEF(sa) system with its counterparts in Gram-negative bacteria, particularly Escherichia coli.

Main Methods:

  • Overexpression of MazEF(Sa) to observe effects on cell growth and viability.
  • In vitro and in vivo assays using ctpA mRNA as a substrate to determine MazF(Sa) endoribonuclease activity and specificity.
  • Binding studies to confirm the interaction between MazE(Sa) and MazF(Sa).
  • Analysis of mazEF(sa) transcription levels under antibiotic stress.

Main Results:

  • Overexpression of MazF(Sa) caused rapid cell growth arrest and loss of viable colony-forming units (CFU).
  • MazF(Sa) was identified as a sequence-specific endoribonuclease cleaving mRNA at specific uracil residues (VUUV' consensus sequence).
  • The antitoxin MazE(Sa) binds MazF(Sa), inhibiting its endoribonuclease activity.
  • Antibiotic exposure increased mazEF(sa) transcription, contrasting with E. coli systems.

Conclusions:

  • The S. aureus mazEF system functions as a toxin-antitoxin module, inhibiting protein synthesis via mRNA cleavage.
  • MazF(Sa) exhibits distinct mRNA cleavage specificity compared to E. coli MazF.
  • The upregulation of mazEF(sa) by antibiotics highlights differences in stress response mechanisms between S. aureus and Gram-negative bacteria.

Related Concept Videos

Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...